Literature DB >> 10331573

Bilateral ovarian carcinoma metastatic from the ampulla of Vater: a rare Krukenberg tumor.

K H Kim1, C D Kim, H S Lee, J H Hyun, Y S Kim, I S Kim.   

Abstract

Carcinoma of the ampulla of Vater is a relatively rare neoplasm and its longterm survival rate is considerably high. However, because of differences in tumor pathologic features and local invasiveness, a 5-year survival rate differ widely. We present a case of metastatic carcinoma of the ampulla of Vater presenting as a Krukenberg tumor in a 59-year-old woman. Eight months earlier, she had been diagnosed as well-differentiated adenocarcinoma of the ampulla of Vater. Abdominal examination revealed a hard mass with mild tenderness in the RLQ area. The laboratory findings were unremarkable except for mild anemia. CT scan of the abdomen revealed enlargement of both ovaries. An exploratory laparotomy disclosed bilateral ovarian masses, 18 x 12 x 8 cm and 8 x 5.5 x 4 cm in size, respectively. Histologic findings of the both ovarian masses were consistent with metastatic adenocarcinoma from the ampulla of Vater.

Entities:  

Mesh:

Year:  1999        PMID: 10331573      PMCID: PMC3054352          DOI: 10.3346/jkms.1999.14.2.220

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  3 in total

1.  Metastatic factors for Krukenberg tumor: a clinical study on 102 cases.

Authors:  Li Qiu; Ting Yang; Xue-Hua Shan; Ming-Bai Hu; Yan Li
Journal:  Med Oncol       Date:  2010-07-07       Impact factor: 3.064

2.  Bone and brain metastases from ampullary adenocarcinoma.

Authors:  Ioannis A Voutsadakis; Stergios Doumas; Konstantinos Tsapakidis; Maria Papagianni; Christos N Papandreou
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

3.  Usefulness of follow-up after pancreatoduodenectomy for carcinoma of the ampulla of Vater.

Authors:  Laurence Chiche; Barbara Alkofer; Jean-Jacques Parienti; Vincent Rouleau; Ephrem Salamé; Guy Samama; Philippe Segol
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.